Israel's Cannbit eyes medical cannabis growth, export in Portugal
Published Dec 03, 2018 05:35AM ET
Israel's Cannbit eyes medical cannabis growth, export in Portugal
JERUSALEM (Reuters) - Cannbit (TA:CPHO), an Israeli grower of medical cannabis, said on Monday it was examining the possibility of establishing a cannabis farm in Portugal as part of its strategy to expand outside of Israel.
Cannbit said it was possible to grow medical cannabis in Portugal and export it from there, with the necessary licenses and permits required by authorities in the country.
"We continue to implement our growth strategy, which includes the establishment of farms in Israel and abroad, in order to grow medical cannabis and sell it both in Israel and abroad," said CEO Yaron Razon.
He noted that includes sales to Canada's Namaste, which bought a 10 percent stake in Cannbit in June even before the firm receives an export permit from Israel.
Export of medical cannabis in Israel is not yet allowed but the government has been reviewing the matter after taking initial steps toward creating an export policy.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.